Table 8.
Effects of CL-316,243 3 on VO2 in WT and UCP-1 KO mice – statistical results.
| 0.04 mg/kg CL-316,243 – VO2 | df | F | p |
|---|---|---|---|
| Genotype | 1,14 | 7.3 | <0.05 |
| Treatment | 1,14 | 8.1 | <0.05 |
| Treatment × genotype | 1,14 | 0.7 | n.s. |
| 0.2 mg/kg CL-316,243 - VO 2 | df | F | p |
| Genotype | 1,14 | 4.2 | n.s. |
| Treatment | 1,14 | 30.7 | <0.05 |
| Treatment × genotype | 1,14 | 12.3 | <0.05 |
| 1 mg/kg CL-316,243 - VO 2 | df | F | p |
| Genotype | 1,14 | 9.2 | <0.05 |
| Treatment | 1,14 | 70.7 | <0.05 |
| Treatment × genotype | 1,14 | 13.0 | <0.05 |